Search for: "WATSON PHARMACEUTICALS "
Results 241 - 260
of 359
Sorted by Relevance
|
Sort by Date
16 Nov 2009, 2:42 pm
Following developments since Watson and Crick discovered the double helix structure of DNA in 1953, Dutfiled leads us through the intertwining workings of genomics and money. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
8 Mar 2011, 7:54 am
Generic versions of Topamax, known generally as topiramate, are sold by Teva Pharmaceuticals, Watson Pharmaceuticals, and Mylan as well as other generic drug companies. [read post]
7 Jan 2013, 9:02 am
Watson Pharmaceuticals — legality under federal antitrust law of payment by a brand-name drug maker to a maker of a generic counterpart, to delay the generic drug’s market entry (Justice Samuel Alito, Jr., is recused.) [read post]
3 Nov 2011, 9:55 am
Watson Pharmaceuticals, Inc., 629 F. [read post]
10 Jun 2013, 9:30 pm
Watson Pharmaceuticals, Inc, a case raising the question of the legality of these agreements. [read post]
20 Jul 2011, 4:04 am
– Economic Times reports ‘Letter of Understanding’ between EU and India (Spicy IP) (Generic Pharmaceuticals and IP) France considers paralysing IP rights on the appearance of generic drugs (Class 46) India: Application of Orphan Drug Act to section 3(d)? [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
28 Jun 2011, 6:30 am
In addition, following the submission of one of the proposals (to Watson Pharmaceuticals, Inc.), the company announced a plan to bring a declassification proposal to a vote at its 2011 annual meeting. [read post]
3 Jan 2008, 7:22 am
Michael Townes Watson, author of America's Tunnel Visionâ€â [read post]
12 Jun 2017, 3:00 am
Partially an advertisement for IBM’s Watson data analytics and insight services (“cognitive engine”), the presentation gave a taste of things to come for pharmaceutical companies and their advisers. [read post]
15 Nov 2012, 7:50 am
Watson of the U.S. [read post]
6 Jul 2011, 2:21 am
(2) (PatLit) Lidoderm (Lidocaine) – US: Delaware District Court decision in Endo Pharmaceuticals patent case favors Watson (GenericsWeb) Lidoderm (Lidocaine) – US: Endo files patent infringement suit against Watson in response to Para IV challenge (Patent Docs) Lipitor (Atorvastatin) – UK: English Patent Court grants temporary restraining order against Teva on short notice – Pfizer threatens pharmacies with legal action over generic Atorvastatin… [read post]
4 May 2011, 4:13 am
Purepac Pharmaceutical, et. al. [read post]
4 Nov 2009, 4:03 am
(IP finance) Brazil: BPTO v ANVISA (Health National Surveillance Agency): Pharmaceutical patents in Brazil (IP tango) Canada finds patents no help for poorest in need of medicine (IP Watch) Ecuador grants obligatory patent licenses (IP tango) (IP tango) (IP tango) India: Glenmark Pharmaceuticals and Suven Life Sciences: The new face of the innovating ‘Indian’ pharma industry? [read post]
10 Apr 2012, 1:15 pm
The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals; and Loryna, a generic version of YAZ, and Syeda, a generic version of Yasmin. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
